Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension

Journal of Hypertension

Volumn 17, Issue 8, 1999, Pages 1161-1168

  Watanabe, Kouki ^a,d   Sekiya, Michihito ^b   Tsuruoka, Takashi ^a   Funada, Jun Ichi ^b   Kameoka, Hiroshi ^a   Miyagawa, Masao ^b   Kohara, Katsuhiko ^c  

^a Minamiuwa Ehime Pref Hospital   (Japan)

^b National Hospital Organization Ehime Medical Center   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Saiseikai Saijo Hospital   (Japan)

Author keywords

Cardiac sympathetic nervous function; Hypertension; Insulin resistance; Iodine 123 metaiodobenzylguanidine; Radionuclide imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; GLUCOSE; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART SCINTISCANNING; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; NORADRENALIN BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYMPATHETIC TONE;

EID: 0032784612     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917080-00016     Document Type: Article

References (55)

1. 1 Rowe JW, Young JB, Miwaker KL, Stevens AL, Palotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30:219-225.
2. 2 Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991; 17:669-677.
3. 3 Friedberg CE, Koomans HA, Bijlama JA, Rabelink TJH, Dorhout Mees EJ. Sodium retention by insulin may depend on decreased plasma potassium. Metabolism 1991; 55:845-855.
4. 4 DeFronzo RA. The effect of insulin on renal sodium metabolism. Diabetlogia 1981; 21:165-171.
5. 5 Trovati M, Massucco P, Anfossi G, Cavalot F, Mularoni E, Mat-tiello L, et al. Insulin influences the renin-angiotensin-aldosterone system in humans. Metabolism 1989; 6:501 -503.
6. 6 Levy D, Garisson RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
7. 7 Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993; 88:1431-1436.
8. 8 Morimoto S, Terada K, Keira N, Satoda M, Inoue K, Tatsukawa H, et al. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging. Eur J Nucl Med 1996; 23:756-761.
9. 9 Kuwahara T, Hamada M, Hiwada K. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. J Nucl Med 1998; 39:1486-1491.
10. 10 Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, et al. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 1979; 25:1461-1470.
11. 11 Esler M, Jennings G, Korner P, Blombery P, Sachrias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984; 247:E21 -E28.
12. 12 Sundlof G, Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol 1977; 272:383-397.
13. 13 Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinate norepinephrine storage analog. J Nucl Med 1981; 22:22-31.
14. 14 Schofer J, Spielmann R, Schuchert A, Weber K, Svhluter M. Iodine 123 metaiodobenzylguanidine scintigraphy: a non-invasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12:1252-1258.
15. 15 McGhie AI, Corbett JR, Akers MS, Kulkarni P, Sills MN, Kremers M, et al. Regional cardiac adrenergic function using 1123 meta-iodobenzylguaniine tomographic imaging after acute myocardial infarction. Am J Cardiol 1991; 67:236-242.
16. 16 Gohl K, Feistel H, Weikl A, Backmann K, Wolf F. Congenital myocardial sympathetic dysinnervation (CMSD) - a structural defect of idiopathic long QT syndrome. Pace 1991; 14:1544-1553.
17. 17 Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzyl-guanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent ischemia. J Am Coll Cardiol 1995; 25:610-618.
18. 18 Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, Kumano S. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med 1997; 38:577-581.
19. 19 Freidwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
20. 20 Shen SW, Reaven GM, Farquhar J. Comparison of impedence to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970; 49:2151-2160.
21. 21 Harano Y, Hidaka H, Takatsuki K, Ohgaku S, Haneda M, Motoi S, et al. Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 1978; 27 (suppl):1449-1452.
22. 22 Sahn DJ, DeMaria A, Kissto J, Weyman A. Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
23. 23 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55:613-618.
24. 24 Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of adrenergic nervous system integrity and function. J Nucl Med 1987; 28:1620-1624.
25. 25 Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens 1989; 11 (suppl 1):75-89.
26. 26 Ganguly PK, Beamish RE, Dhalla KS, Innes IR, Dhalla NS. Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol 1987; 252:E734-E739.
27. 27 Morizumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, et al. Myocardial iodine-123-metaiodobenzyl-guanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997; 38:49-52.
28. 28 Sassa H. Mechanism of myocardial catecholamine depletion in cardiac hypertrophy and failure in rabbits. Jpn Circ J 1971; 35:391-403.
29. 29 Fushimi H, Inoue T, Kishino B, Nishikawa M, Tochino Y, Funakawa S, et al. Abnormalities in plasma catecholamine response and tissue catecholamine accumulation in streptozotocin diabetic rats, a possible for diabetic autonomic neuropathy. Life Sci 1984; 35:1077-1081.
30. 30 Schofer J, Spielmann R, Schchert A, Weber K, Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12:1252-1258.
31. 31 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
32. 32 Grrenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981; 30:387-392.
33. 173I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 1994; 15:317-323.
34. 34 Kelm M, Schäfer S, Mingers S, Heydthausen M, Vogt M, Motz W, et al. Left ventricular mass is linked to cardiac norepinephrine in normotensive and hypertensive patients. J Hypertens 1996; 14:1357-1364.
35. 35 Lind L, Anderson PE, Andrén B, Hänni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13:433-438.
36. 36 Paolisso G, Galderisi M, Tagliamonte MR, Divitis M, Galzerano D, Petrocelli A, et al. Myocardial wall thickness and left ventricualr geometry in hypertensives: relationship with insulin. Am J Hypertens 1997; 10:1250-1256.
37. 37 Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role on insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-381.
38. 38 Donohue TJ, Dwoekin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, et al. Induction of myocardial insulin-like growth factor-1 gene expression in left ventricular hypertrophy. Circulation 1994; 89:799-809.
39. 39 Sowers JR, Standley PR, Ram JL, Jacober S, Simpson L, Rose K. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993; 6:260S-270S.
40. 40 Julius S, Gudbrandsson T. Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharm 1992; 20:540-548.
41. 41 Dubois EA, Kam KL, Somsen GA, Boer GJ, Bruin K, Batink HD, et al. Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension. Eur J Nucl Med 1996; 23:901-908.
42. 42 Chang CJ, Wu JS, Lu FH, Liu IM, Chi TC, Cheng JT. Sympathetic hyperactivity in wistar rats with insulin-resistance. Jauton Nerv Syst 1998; 74:116-119.
43. 43 Hall JE, Brands MW, Dixon WN, Smith Jr MJ. Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension 1993; 22:292-299.
44. 44 Sakata K, Shirotani M, Yoshida H, Kurata C. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension. J Am Coll Cardiol 1998; 32:438-443.
45. 45 Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975; 36:319-327.
46. 46 Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension 1992; 19 (suppl 1):37-77.
47. 47 Smith U. Insulin resistance in hypertension. In: Moler DE (editor): Insulin resistance. Chichester: John Wiley & Sons; 1993. pp. 1-8.
48. 48 Stout RW. Insulin and atheroma-20 year perspective. Diabetes Care 1990; 13:631-654.
49. 49 Rönnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991; 11:80-90.
50. 50 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, et al. Weight reducing effects of the plasma protein enclosed by the obese gene. Science 1995; 269:543-546.
51. 51 Segal KR, Landt M, Kloin S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45:988-991.
52. 52 Zimmer PZ, Collins VR, de Couurten MP, Hodge AM, Collier GR, Dowse GK, et al., on behalf of Mauritus NCD Study Group. Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Int J Obes 1998; 22:171-177.
53. 53 Haynes WG, Morgan DA, Walsh SA, Sivitz WI, Mark AL. Cardiovascular consequences of obesity: role of leptin. Clin Exp Pharmacol Physiol 1998; 26:65-69.
54. 54 Shek EW, Brands MW, Hall JE. Chronic leptin increases arterial pressure. Hypertension 1998; 31:409-414.
55. 55 Kohara K, Hara-Nakamura N, Hiwada K. Left ventricular mass index negatively correlates with heart rate variability in essential hypertension. Am J Hypertens 1995; 8:183-188.